Vontobel Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$728M Sell
9,982,924
-991,645
-9% -$63.8M 4.04% 7
2023
Q4
$668M Buy
10,974,569
+1,015,140
+10% +$54.2M 3.98% 9
2023
Q3
$565M Sell
9,959,429
-9,685
-0.1% -$508K 3.66% 11
2023
Q2
$577M Sell
9,969,114
-2,509,521
-20% -$131M 3.82% 9
2023
Q1
$670M Sell
12,478,635
-387,779
-3% -$18.3M 4.84% 6
2022
Q4
$638M Buy
12,866,414
+248,625
+2% +$10.8M 5.07% 5
2022
Q3
$535M Sell
12,617,789
-345,012
-3% -$13.8M 4.23% 8
2022
Q2
$516M Sell
12,962,801
-50,496
-0.4% -$2.06M 3.77% 9
2022
Q1
$604M Sell
13,013,297
-750,992
-5% -$32.5M 4% 8
2021
Q4
$613M Buy
13,764,289
+1,988,691
+17% +$83.6M 3.6% 10
2021
Q3
$532M Sell
11,775,598
-773,964
-6% -$34.2M 2.99% 12
2021
Q2
$555M Sell
12,549,562
-1,045,307
-8% -$44M 2.85% 10
2021
Q1
$545M Buy
13,594,869
+1,342,311
+11% +$50.8M 3.31% 9
2020
Q4
$458M Buy
12,252,558
+2,296,721
+23% +$82.8M 2.7% 10
2020
Q3
$401M Buy
9,955,837
+1,461,587
+17% +$56.3M 2.41% 12
2020
Q2
$316M Buy
8,494,250
+166,155
+2% +$5.98M 2.12% 16
2020
Q1
$293M Buy
8,328,095
+3,027,782
+57% +$118M 2.21% 19
2019
Q4
$252M Sell
5,300,313
-16,194
-0.3% -$678K 1.6% 23
2019
Q3
$230M Buy
5,316,507
+442,715
+9% +$18.8M 1.55% 26
2019
Q2
$216M Buy
4,873,792
+3,462,586
+245% +$133M 1.62% 27
2019
Q1
$54.2M Sell
1,411,206
-229,266
-14% -$8.76M 0.43% 42
2018
Q4
$58M Buy
1,640,472
+236,059
+17% +$8.56M 0.5% 43
2018
Q3
$54.1M Sell
1,404,413
-175,321
-11% -$6.12M 0.41% 47
2018
Q2
$51.7M Sell
1,579,734
-67,281
-4% -$2.03M 0.38% 47
2018
Q1
$45M Sell
1,647,015
-4,565
-0.3% -$124K 0.32% 45
2017
Q4
$40.9M Buy
1,651,580
+266,067
+19% +$7.34M 0.29% 46
2017
Q3
$40.4M Buy
1,385,513
+728,832
+111% +$20.1M 0.29% 45
2017
Q2
$18.2M Buy
+656,681
New +$17.4M 0.14% 49

Other funds holding BSX